Schedule (Drug Scheduling)
A classification system categorising controlled substances based on medical utility and abuse potential. The US uses Schedules I-V, the UK uses Classes A-C and Schedules 1-5. Scheduling status varies by jurisdiction, which is why PeptideTrace tracks legal status across multiple countries.
Technical Context
International scheduling frameworks: US — 5 schedules under CSA (DEA classification, HHS recommendation to DEA based on 8-factor analysis including abuse potential, pharmacological effect, current scientific knowledge, psychic/physiological dependence liability, scope of abuse, risk to public health, and whether the substance is a precursor); UK — 3 classes under Misuse of Drugs Act 1971 (Class A, B, C — determining maximum penalties) PLUS 5 schedules under Misuse of Drugs Regulations 2001 (Schedule 1-5 — determining prescribing/dispensing rules); EU — member states implement UN conventions with national variations; Canada — 8 schedules under Controlled Drugs and Substances Act; Australia — 10 schedules under Standard for the Uniform Scheduling of Medicines and Poisons. These different frameworks mean a compound may be scheduled differently across jurisdictions — PeptideTrace tracks legal status across jurisdictions precisely because of these variations.